Search
for
Sort by
Research 61–90 of 1000+
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Hormonal manipulation of benign prostatic hyperplasia
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
- Frontal fibrosing alopecia: efficacy of treatment modalities
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- Post-finasteride syndrome – does it really exist?
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- COVID‐19, androgens, and androgenic alopecia
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- Evaluation of men on finasteride.
- Comparison of clinical trials with finasteride and dutasteride.
- The Benefits of Dual Inhibition of 5α Reductase
- Table_2.docx
- Table_1.docx
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome